In contrast, METTL3 has demonstrated a tumour suppressive role in other cancer types such as renal cell carcinoma (RCC) and colorectal cancer (Li et al., 2017; Deng et al., 2019). This evidence concerns the gene METTL3 and renal cell carcinoma.